Search clinical trials for: Itraconazole/voriconazole

Total 519 results

Jonsson Comprehensive Cancer Center

Completed

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Cancer

United States
Rennes University Hospital

Completed

ATCF (Azole Therapy in Cystic Fibrosis) (ATCF)

Cystic Fibrosis | Aspergillus Infections

France, United Kingdom
Post Graduate Institute of Medical Education and...

Completed

A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary Aspergillosis

Chronic Pulmonary Aspergillosis

India
Pfizer

Completed

Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT) (IMPROVIT)

Antifungal Prophylaxis of Invasive Fungal Infections

Canada, Spain, Greece, France, Portugal, United Kingdom, Czech Republic, Egypt, Jordan, Russian Federation, Switzerland, Turkey
University of Maryland, Baltimore

Completed

Itraconazole Oral Absorption

Fungal Infection

United States
Farabi Eye Hospital

Unknown

UVX as an Adjuvant in the Treatment of Fungal Keratitis

Treatment
Taro Pharmaceuticals USA

Completed

A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis

Tinea Pedis
dingshifang
Shandong Provincial Hospital; Qianfoshan Hospital; Jinan Military General Hospital and other collaborators

Unknown

CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients

Invasive Pulmonary Aspergillosis

China
Pfizer
University of Southern California

Completed

Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients, 2002-2009g

Non-Melanoma Skin Carcinoma
Galapagos NV

Completed

A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Doses of Itraconazole and Voriconazole Are Given to Healthy Volunteers

Healthy

United Kingdom
Astellas Pharma Europe B.V.
World Health Information Science Consultants, LLC

Completed

Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents (MYCOS)

Systemic Fungal Infections

United States
Chong Kun Dang Pharmaceutical

Completed

Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers

Fungal Infections | Candida Infections | Aspergillus Infections

Korea, Republic of
Pfizer

Completed

Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection

Candidemia | Candidiasis

United States
Sara Botros

Completed

Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel

Tinea Versicolor

Egypt
Seoul National University Hospital

Completed

Influence of SLCO2B1 Polymorphism on the PK of Voriconazole in CYP2C19 PM

Healthy Volunteers

Korea, Republic of
Jan-Willem C Alffenaar
UMC Utrecht; Erasmus Medical Center; Amsterdam UMC, location VUmc; Academisch Medisch... and other collaborators

Completed

Pharmacologic Optimization of Voriconazole (VORI911)

Invasive Fungal Infection | Hematological Malignancy

Netherlands
Minia University

Completed

Clinical Assessment of Oxiconazole Nitrate Solid Lipid Nanoparticles Loaded Gel

Tinea

Egypt
University of Alabama at Birmingham
Washington University School of Medicine; University of California, Davis

Completed

Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole (MSG15)

Invasive Fungal Infections

United States, Panama
The Affiliated Hospital of Qingdao University

Completed

Comparative Study on Tolerance and Pharmacokinetics of Voriconazole for Injection in Healthy Subjects

Healthy Adults

China
Zambon SpA

Completed

Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects

Allergic Bronchopulmonary Aspergillosis

United Kingdom
Instituto de Investigación Hospital Universitario...

Unknown

Effectiveness and Efficiency of a Voriconazole Preemptive Genotyping Strategy (VORIGENPHARM)

Invasive Fungal Infections

Spain
Manjunath Prakash Pai
Pfizer; TKL Research, Inc.

Completed

Pharmacokinetics of Voriconazole in Obese Subjects

Healthy

United States
Pfizer

Completed

Voriconazole (Vfend) Special Investigation (Regulatory Post Marketing Commitment Plan)

Scedosporium Infection
Yung Shin Pharm. Ind. Co., Ltd.
Taichung Veterans General Hospital

Completed

Pharmacokinetics of Two Different Formulation of Voriconazole

Fungus Infection
Pfizer

Completed

Voriconazole (Vfend) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Systemic Mycosis
University of California, San Francisco

Completed

Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer

Prostate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage III Prostate Adenocarcinoma AJCC v7 | Stage I Prostate Adenocarcinoma AJCC v7 | Stage II Prostate Adenocarcinoma AJCC v7

United States
Jean Yuh Tang
National Cancer Institute (NCI)

Completed

Topical Itraconazole in Treating Patients With Basal Cell Cancer

Skin Basal Cell Carcinoma

United States
Johns Hopkins University
Memorial Sloan Kettering Cancer Center

Completed

A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy

Prostate Cancer

United States
Turku University Hospital

Completed

Effects of Voriconazole on the Pharmacokinetics and Pharmacodynamics of Oral Buprenorphine: A Two-phase Cross-over Study in Healthy Subjects

Healthy

Finland
Montreal Heart Institute

Terminated

Evaluation of the Response of Itraconazole and Terbinafine Therapy in Subjects With Crohn's Disease (CD-IT)

Inflammatory Bowel Diseases | Crohn's Disease

Canada
Asan Medical Center

Terminated

Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy

Invasive Fungal Infection

Korea, Republic of
Pfizer
Infectious Diseases Working Party (AGIHO) of the German Society of Hematology...

Completed

Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic Patients (IDEA)

Possible Fungal Infection

Germany
Pfizer

Completed

A Study Of Indian Patients Receiving Therapy For Systemic Fungal Infections

Systemic Fungal Infections

India
Phillip Brian Smith
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease

Stem Cell Transplantation | Graft Versus Host Disease

United States
Pfizer
McLean Hospital. Belmont, MA.

Completed

To Determine The Amount Of Voriconazole In The Brain After 2 Loading Doses And 3 Maintenance Doses Over 3 Days

Infections, Fungal

United States
Turku University Hospital

Completed

Effects of Posaconazole and Voriconazole on the Pharmacokinetics and Pharmacodynamics of Sublingual Buprenorphine (PosaBupre)

Pharmacokinetics and Pharmacodynamics of Sublingual Buprenorphine

Finland
Sara Botros

Completed

Clinical Assessment of Itraconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel

Tinea Versicolor

Egypt
Pulmatrix Inc.

Completed

Safety, Tolerability and Pharmacokinetics of PUR1900 (Itraconazole Powder) in Healthy Volunteers and Adults With Asthma

Asthma

United Kingdom
Astellas Pharma Inc

Withdrawn

A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis

Aspergillosis/Blood | Aspergillosis/Invasive

United States
Pfizer

Completed

Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection (Ve-RIFI)

Invasive Fungal Infections
Pfizer

Completed

A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults

Healthy Volunteers

Belgium
Pfizer

Completed

A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections

Invasive Fungal Infections

China
University of Kansas Medical Center
University of Texas, Southwestern Medical Center at Dallas

Recruiting

Itraconazole to Prevent Recurrent Barrett's Esophagus

Barrett Oesophagitis With Dysplasia

United States
Halcygen Pharmaceuticals Limited

Completed

Study Comparing SUBA™-Itraconazole With SPORANOX® (Itraconazole) in the Treatment of Onychomycosis

Onychomycosis

United States
H. Lundbeck A/S

Completed

Study Evaluating the Effect of Multiple Doses of Itraconazole on the Drug Lu AF35700 in Healthy Young Men and Women

Cytochrome P450 Interaction

United Kingdom, United States
Brynn Chappell
The Christie NHS Foundation Trust

Suspended

Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy (PIVOTAL)

Aspergillosis | Immunocompromised Patient | Fusarium

United Kingdom
Pfizer

Completed

Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection

Aspergillosis, Aspergilloma

Japan
Pfizer

Completed

Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® IV

Serious Fungal Infections
Pfizer

Completed

Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet In Korea

Serious Fungal Infections
Samyang Biopharmaceuticals Corporation

Completed

Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend)

Systemic Mycotic Infection

Korea, Republic of

3

Subscribe